Living Cell Technologies Limited (ASX:LCT) Share Price, News, Chart & Financials

Living Cell Technologies Limited

C/O Mertons Corporate Services, Level 7, 330 Collins Street, MELBOURNE, VIC, AUSTRALIA, 3000

64 9276 2690

http://www.lctglobal.com/

Sector: Healthcare

Description

Listed in year 2004, Living Cell Technologies Limited (ASX: LCT) is a cell therapy based company that is working towards neurodegenerative diseases. The Australasian company is emerging as a biotech player that aims to develop and commercialize regenerative treatments and its lead product, known as NTCELL®, is an alginate coated capsule that has clusters of neonatal porcine choroid plexus cells to help growth and repair nerve degeneration.

Peers

SUD

Suda Pharmaceuticals Ltd.

NOX

Noxopharm Limited

NVAX

Novavax Inc

ANP

Antisense Therapeutics Ltd.

BPH

BPH Energy Limited

CHM

Chimeric Therapeutics Limited

CYP

Cynata Therapeutics Limited

NYR

Nyrada Inc.

PFE

Pfizer Inc

MRNA

Moderna Inc

IMU

Imugene Limited

RAD

Radiopharm Theranostics Limited

Close

Living Cell Technologies Limited

Living Cell Technologies Limited

Description

Peers

SUD

NOX

NVAX

ANP

BPH

CHM

CYP

NYR

PFE

MRNA

IMU

RAD

Sponsored Articles

Related Articles